Oct
2026
Fiera Milano, Italy
Visit us
stand 18B41, Finished Dosage & Formulation

Royalmount Biopharma Services

Exhibitor at CPHI Milan 2026
About Us

Royalmount Biopharma Services, a division of Pharmascience, featuring two business units: CDMO Services & Lab Services. Our Lab division delivers high-precision bioanalytical services for preclinical and clinical studies using advanced platforms. CDMO Services, at our FDA-approved facility, provides end-to-end development for small & large molecules, including cytotoxic products, with exclusive partnerships enabling preclinical and clinical trials. RBS combines scientific excellence, regulatory expertise, & operational agility to support biopharmaceutical partners.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Canada
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Contract Manufacturer
Contract Research Organisation
Laboratory Services
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 18B41, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Analytical Laboratory Services

    Product Analytical Laboratory Services

    Royalmount Laboratories boast a purpose-built, partially automated, state-of-the-art GLP certified and FDA inspected laboratory. This laboratory provides robust bioanalytical method development and validation for quantification of drugs and metabolites in biological fluids/tissues using LC/MS/MS technology...
  • Contract Development Manufacturing Services

    Product Contract Development Manufacturing Services

    Our expert R&D and manufacturing team delivers FDA & EMA approved turnkey solutions delivering CDMO and CMO competitive advantages for sterile cytotoxic injectables and solid dosage forms.